ARTESUNATE AND ESOMEPRAZOLE ADD-ONS TO LOW-DOSE ASPIRIN IN THE PREVENTION AND TREATMENT OF PLACENTAL MALARIA, PRE-ECLAMPSIA, FETAL GROWTH RESTRICTION AND METABOLIC SYNDROME: A MECHANISTIC REVIEW AND CLINICAL REPORT

Journal Title: World Journal of Pharmaceutical and life sciences - Year 2017, Vol 3, Issue 5

Abstract

Recent evidence indicates that malaria, type 2 diabetes mellitus and hypertension constitute a ‘triumvirate’ that significantly increases the suffering in Africa. The contribution of malaria to the alliance may be via the up-regulation of inflammatory and oxidative stress which attenuate factors of the insulin signalling pathway. Upregulation of immune-inflammatory cascade and ThI/Th17 reponse is a common mechanism in severe malaria, placental malaria, pre-eclampsia, hypertension, type 2 diabetes mellitus, auto-immune diseases and fetal growth restriction with placental insufficiency. Safe drugs that attenuate inflammatory and oxidative stress, decrease ThI/Th17 response, upregulate factors of the insulin signalling pathway and which kill the ring/early forms of the malaria parasite in the blood which particularly mediate the oxidative stress stand to be beneficial in these diseases. Rigorous supervision of malaria treatment with ACTs decreases umbilical artery resistance index in microscopic and submicroscopic placental malaria which has identical aetiopathogenic mechanisms with pre-eclampsia. The improved ACT campaign may have co-incided with the significant (P< 0.05) decrease in eclampsia rates observed 2012-2016. Artesunate, esomeprazole, low-dose aspirin, calcium and vitamin A supplementation may upregulate factors of the insulin signalling pathway, enhance the actions of heme oxygenase –I and endothelial nitric oxide. They thus deserve attention as emerging agents that additively may enhance insulin signalling, and down-regulate the immune-inflammatory cascade, angiogenic/anti-angiogenic imbalance in type 2 diabetes, hypertension, severe malaria, placental malaria, pre-eclampsia and fetal growth restriction.

Authors and Affiliations

Dr. S. E. Oriaifo

Keywords

Related Articles

A REVIEW: NATURAL ANTI-OBESITY DRUGS

Obesity is a global health concern associated with high morbidity and mortality. Obesity is resulting from an energy imbalance caused by an increased ratio of caloric intake to energy expenditure. Therapeutic strategies...

SURVEY OF VASCULAR EPIPHYTES IN SELECTED AREAS IN ZAMBOANGA CITY, PHILIPPINES

Epiphytes are considered to be as one of the most important component in a forest since they accumulate biomass, serve as habitat for some animals, help in water and other nutrient cycle and possess aesthetic value. Howe...

A MODELING BASED PREDICTIVE TOOL FOR CENTRAL NERVOUS SYSTEM DRUGS USING CHROMATOGRAPHY

51 central nervous system (CNS) drugs, clinically established to enter blood brain barrier (BBB), were characterized in terms of their chromatographic behavior in order to develop a predictive model for candidate drugs i...

DIVERSE CLINICAL FUNCTIONS OF SERINE PROTEASE AND ITS INHIBITORS

Serine protease performs normal biological functions in cell. Serine protease are involves in coagulation, inflammation and immunity. Wide variety organisms produce serine proteases including virus, bacteria, animals and...

EFFECT OF SUBSTITUENTS ON COOXIDATION RATE OF AROMATIC ANILS AND OXALIC ACID BY CHROMIC ACID

Though aromatic anils are said to be very sluggish towards Cr(VI) in presence of aqueous acetic acid medium, it can be easily oxidized in presence of oxalic acid, where it is proposed that an intermediate is formed betwe...

Download PDF file
  • EP ID EP649104
  • DOI -
  • Views 195
  • Downloads 0

How To Cite

Dr. S. E. Oriaifo (2017). ARTESUNATE AND ESOMEPRAZOLE ADD-ONS TO LOW-DOSE ASPIRIN IN THE PREVENTION AND TREATMENT OF PLACENTAL MALARIA, PRE-ECLAMPSIA, FETAL GROWTH RESTRICTION AND METABOLIC SYNDROME: A MECHANISTIC REVIEW AND CLINICAL REPORT. World Journal of Pharmaceutical and life sciences, 3(5), 1-13. https://europub.co.uk/articles/-A-649104